Geisen; Karl

Patent Applications and Registrations

Patent applications and USPTO patent grants for Geisen; Karl.The latest application filed is for "process for producing medicaments which comprise hmg coa reductase inhibitors".

Company Profile

0.14.3

Geisen; Karl - Frankfurt DE
Geisen, Karl - Koln DE
Geisen; Karl - Frankfurt am Main DE

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Insulin analogs with enhanced zinc binding Grant 6,686,177 - Ertl , et al. February 3, 2	2004-02-03
Process for producing medicaments which comprise HMG CoA reductase inhibitors App 20030203964 - Schuckler, Fritz ; et al.	2003-10-30
Use of polycyclic 2-aminothiazole systems for the treatment of obesity Grant 6,476,059 - Jahne , et al. November 5, 2	2002-11-05
Method For Producing Medicaments Containing Hmg-coa-reductase Inhibitors App 20020146454 - SCHUCKLER, FRITZ ; et al.	2002-10-10
Polycyclic thiazol-2-ylidene amines, processes for their preparation and their use as medicaments App 20010011096 - Jahne, Gerhard ; et al.	2001-08-02
Polycyclic 2- aminothiazole systems, processes for their preparation and pharmaceuticals comprising these compounds Grant 6,251,922 - Jahne , et al. June 26, 2	2001-06-26
Insulin derivatives having a rapid onset of action Grant 6,221,633 - Ertl , et al. April 24, 2	2001-04-24
Polycyclic thiazole systems, processes for their preparation and pharmaceuticals comprising these compounds Grant 6,187,801 - Jahne , et al. February 13, 2	2001-02-13
Polycyclic thiazolidin-2-ylidene amines, process for their preparation, and their use as pharmaceuticals Grant 6,159,996 - Jaehne , et al. December 12, 2	2000-12-12
Use of pyrimidine derivatives for the prevention of cancer, on their own or in combination with other therapeutic measures Grant 6,156,755 - Geisen December 5, 2	2000-12-05
Insulin derivatives, a process for the preparation thereof, the use thereof, and a pharmaceutical formulation containing them Grant 5,506,202 - Vertesy , et al. April 9, 1	1996-04-09
Amorphous monospheric forms of insulin derivatives Grant 5,466,666 - Obermeier , et al. November 14, 1	1995-11-14
Heterocyclic substituted sulfonyl ureas, and their use Grant 4,379,785 - Weyer , et al. April 12, 1	1983-04-12
Thienopyrrolone substituted benezenesulfonylureas and their use Grant 4,325,963 - Hitzel , et al. April 20, 1	1982-04-20
Sulfonyl ureas and pharmaceutical preparations thereof Grant 4,282,239 - Weyer , et al. August 4, 1	1981-08-04
Benzoic acids, their derivatives and process for preparing them Grant 4,221,815 - Weyer , et al. September 9, 1	1980-09-09
Certain nicotinamido-n-benzoic acid derivatives Grant 4,181,658 - Hitzel , et al. January 1, 1	1980-01-01

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.